Oral Metformin for Treating Melasma in Latin American Women
Recruiting
Phase 1
Phase 2
Interventional Study
Melasma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 21 and older
- Sex
- Female
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- University of Puerto Rico · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if metformin can treat melasma in Latin American women. The main question it aims to answer is:
\- Can metformin help reduce the dark patches of melasma?
Researchers will test two different doses of metformin (500 mg and 1000 mg) to see if either one helps improve melasma.
Participants will:
* Take a metformin pill every day for three months.
* Go to…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria: Latin American women aged 21 years or older, diagnosed epidermal or mixed melasma
Exclusion Criteria: pregnancy, breastfeeding, use of hydroquinone or tretinoin within 2 months before the study, or undergoing laser treatment, peels, microdermabrasion, or microneedling within 2 m…
Contacts